Jw Life Science Corp (234080) — Cash Flow Reinvestment Rate
Jw Life Science Corp (234080) has a Cash Flow Reinvestment Rate of 0.84x as of December 2025, reinvesting ₩4.27 Billion (capex ₩4.27 Billion ) from operating cash flow of ₩5.08 Billion. Check how high is Jw Life Science Corp's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jw Life Science Corp Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Jw Life Science Corp across 11 annual periods. Explore 234080 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Jw Life Science Corp (2015–2025)
Year-by-year capital reinvestment analysis for Jw Life Science Corp. For live market cap and broader valuation context, see Jw Life Science Corp market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.33x | ₩13.43 Billion | ₩40.54 Billion | ₩13.43 Billion | ▼ -0.1% |
| 2024 | 0.33x | ₩16.82 Billion | ₩50.69 Billion | ₩10.31 Billion | ▼ -50.7% |
| 2023 | 0.67x | ₩25.28 Billion | ₩37.57 Billion | ₩8.27 Billion | ▼ -74.0% |
| 2022 | 2.59x | ₩36.54 Billion | ₩14.13 Billion | ₩8.29 Billion | ▲ +297.4% |
| 2021 | 0.65x | ₩19.63 Billion | ₩30.17 Billion | ₩18.98 Billion | ▼ -14.6% |
| 2020 | 0.76x | ₩35.63 Billion | ₩46.75 Billion | ₩15.93 Billion | ▲ +128.3% |
| 2019 | 0.33x | ₩8.10 Billion | ₩24.28 Billion | ₩8.09 Billion | ▲ +20.0% |
| 2018 | 0.28x | ₩10.05 Billion | ₩36.13 Billion | ₩10.04 Billion | ▼ -30.7% |
| 2017 | 0.40x | ₩8.85 Billion | ₩22.05 Billion | ₩8.77 Billion | ▼ -73.8% |
| 2016 | 1.53x | ₩24.65 Billion | ₩16.08 Billion | ₩13.37 Billion | ▲ +70.2% |
| 2015 | 0.90x | ₩23.32 Billion | ₩25.90 Billion | ₩23.14 Billion | — |